Related references
Note: Only part of the references are listed.Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
Xingrui He et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Hdac8 Inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1
Tingwei Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer
Garyfallia Pantelaiou-Prokaki et al.
CLINICAL EPIGENETICS (2022)
HDAC Inhibition to Prime Immune Checkpoint Inhibitors
Edith Borcoman et al.
CANCERS (2022)
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa et al.
CELLS (2022)
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Martina Korfei et al.
CELLS (2022)
Long noncoding RNA LINC01435 impedes diabetic wound healing by facilitating YY1-mediated HDAC8 expression
Wan Fu et al.
ISCIENCE (2022)
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability
Stefano Federico et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
Salma Darwish et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Notch signaling: A possible therapeutic target and its role in diabetic foot ulcers
Farmiza Begum et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)
Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8
Zhiqiang Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors
Camille Hauguel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury
Keith Long et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Jiranan Chotitumnavee et al.
CHEMICAL COMMUNICATIONS (2022)
Gene Therapy for Duchenne Muscular Dystrophy
Nertiyan Elangkovan et al.
Journal of Neuromuscular Diseases (2021)
Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function
January M. Watters et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Histone deacetylase 8 inhibition alleviates cholestatic liver injury and fibrosis
Chang Hun Lee et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
Hao Yan et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina et al.
CHEMMEDCHEM (2021)
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
Hongbo Liu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues
Hua Miao et al.
PHARMACOLOGICAL RESEARCH (2021)
Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120/FFA4 mediated pathway
Sarah Mazzotta et al.
BIOORGANIC CHEMISTRY (2021)
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
Nicola Relitti et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype
Olasunkanmi O. Olaoye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
Xin-Hui Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Duchenne muscular dystrophy
Dongsheng Duan et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Andrey D. Bondarev et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
Weiqin Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
Tingwei Zhao et al.
FRONTIERS IN PHARMACOLOGY (2021)
Histone-deacetylase 8 drives the immune response and the growth of glioma
Alessandro Mormino et al.
GLIA (2021)
Inhibiting HDAC3 (Histone Deacetylase 3) Aberration and the Resultant Nrf2 (Nuclear Factor Erythroid-Derived 2-Related Factor-2) Repression Mitigates Pulmonary Fibrosis
Fang Chen et al.
HYPERTENSION (2021)
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
Giuseppe Campiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy
Marco Spreafico et al.
PHARMACOLOGICAL RESEARCH (2021)
The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene
Simonetta Andrea Licandro et al.
SKELETAL MUSCLE (2021)
PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA
Melissa F. Adasme et al.
NUCLEIC ACIDS RESEARCH (2021)
Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation
Abdullahi Ibrahim Uba et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis
Ya-Long Feng et al.
MEDICINAL RESEARCH REVIEWS (2020)
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
Margherita Brindisi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach
Patrizia Sarogni et al.
JOURNAL OF MEDICAL GENETICS (2020)
Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents
Fulvio Saccoccia et al.
ACS INFECTIOUS DISEASES (2020)
Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines
Kalpana Tilekar et al.
BIOORGANIC CHEMISTRY (2020)
Exploring the binding mechanism of HDAC8 selective inhibitors: Lessons from the modification of Cap group
Min Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1
Ehab Ghazy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis
Yunhe Zhang et al.
FASEB JOURNAL (2020)
Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction
Brianna Burke et al.
FRONTIERS IN ONCOLOGY (2020)
Retinitis Pigmentosa and Retinal Degenerations: Deciphering Pathways and Targets for Drug Discovery and Development
Gabriele Carullo et al.
ACS CHEMICAL NEUROSCIENCE (2020)
An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activators
Jintong Du et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Discovery of novel N -substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation
Neha Upadhyay et al.
BIOORGANIC CHEMISTRY (2020)
HDAC8 Inhibition Reduces Lesional Iba-1+Cell Infiltration after Spinal Cord Injury without Effects on Functional Recovery
Sven Hendrix et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mantonico and Pecorello Grape Seed Extracts: Chemical Characterization and Evaluation of In Vitro Wound-Healing and Anti-Inflammatory Activities
Gabriele Carullo et al.
PHARMACEUTICALS (2020)
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting
Muhammad Murtaza Hassan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Baicalein: A metabolite with promising antineoplastic activity
Hardeep Singh Tuli et al.
LIFE SCIENCES (2020)
HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals
Panpan An et al.
ONCOGENE (2020)
Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
Joshua P. Smalley et al.
MOLECULES (2020)
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation
A. Prasanth Saraswati et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia
Marco Spreafico et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Natural HDAC-1/8 inhibitor baicalein exerts therapeutic effect in CBF-AML
Xiaoxuan Yu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
Kamira Maharaj et al.
FRONTIERS IN IMMUNOLOGY (2020)
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Suvankar Banerjee et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
Somy Yoon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Translational research in pulmonary fibrosis
Susan K. Mathai et al.
TRANSLATIONAL RESEARCH (2019)
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
Tessa Knox et al.
SCIENTIFIC REPORTS (2019)
Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease
Mar Cuadrado-Tejedor et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Dual Roles of the AMP-Activated Protein Kinase Pathway in Angiogenesis
Yuanjun Li et al.
CELLS (2019)
Quercetin-3-Oleate Contributes to Skin Wound Healing Targeting FFA1/GPR40
Gabriele Carullo et al.
CHEMISTRYSELECT (2019)
Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity
Prakruti Trivedi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation
Sudhan Debnath et al.
SCIENTIFIC REPORTS (2019)
HDAC8 inhibition ameliorates pulmonary fibrosis
Shigeki Saito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
HDAC8 Inhibitor WK2-16 Therapeutically Targets Lipopolysaccharide-Induced Mouse Model of Neuroinflammation and Microglial Activation
Fan-Li Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases
Nicholas J. Porter et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)
Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors
Benjamin Wolff et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Induction of Apoptosis and Autophagy in Breast Cancer Cells by a Novel HDAC8 Inhibitor
Chang-Fang Chiu et al.
BIOMOLECULES (2019)
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
Xing Lyu et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2019)
Crosstalk between Epigenetic Modulations in Valproic Acid Deactivated Hepatic Stellate Cells: An Integrated Protein and miRNA Profiling Study
Peng Lu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer
Yue Zhong et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
Ryan Lillico et al.
JOURNAL OF PROTEOME RESEARCH (2018)
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
Fiona R. Kolbinger et al.
ARCHIVES OF TOXICOLOGY (2018)
HDAC8 regulates neural differentiation through embryoid body formation in P19 cells
Syouichi Katayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
G. R. Vanaja et al.
CELL COMMUNICATION AND SIGNALING (2018)
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment
Jing Shen et al.
CELL DEATH AND DIFFERENTIATION (2018)
A Functional Mutation in HDAC8 Gene as Novel Diagnostic Marker for Cornelia De Lange Syndrome
Xueren Gao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling
Yun Zhang et al.
CLINICAL SCIENCE (2018)
Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors
Chunlong Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity
Ahmed T. Negmeldin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4
Diana Lamaa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Renal fibrosis: Recent translational aspects
Helene Francois et al.
MATRIX BIOLOGY (2018)
Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement
Antonie D. Kline et al.
NATURE REVIEWS GENETICS (2018)
HDAC Inhibitors: Novel Immunosuppressants for Allo- and Xeno- Transplantation
Qing Zhang et al.
CHEMISTRYSELECT (2018)
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies
Margherita Brindisi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors
Rekha Sangwan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants
Martin Marek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
David Briere et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer
Tushar D. Bhagat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders
Biswanath Dinda et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
Evangelia Pardali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides
Carol Ann Castaneda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity
Tino Heimburg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cinnamaldehyde, Cinnamic Acid, and Cinnamyl Alcohol, the Bioactives of Cinnamomum cassia Exhibit HDAC8 Inhibitory Activity: An In vitro and In silico Study
Mangesh Patil et al.
PHARMACOGNOSY MAGAZINE (2017)
Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?
Sic. Abdul Amin et al.
PHARMACOLOGICAL RESEARCH (2017)
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
Meredith L. Stone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors
Taha Y. Taha et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity
Ahmed Negmeldin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Baicalein as a potent neuroprotective agent: A review
Kandhasamy Sowndhararajan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells
Vijaya Rao Pidugu et al.
APOPTOSIS (2017)
The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity
Ahmed T. Negmeldin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl Lysine
Pornpun Aramsangtienchai et al.
ACS CHEMICAL BIOLOGY (2016)
Structural and Functional Influence of the Glycine-Rich Loop G302GGGY on the Catalytic Tyrosine of Histone Deacetylase 8
Nicholas J. Porter et al.
BIOCHEMISTRY (2016)
Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity
Vijaya Rao Pidugu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Potent and Selective Non-hydroxamate Histone Deacetylase 8 Inhibitors
Alexander Kleinschek et al.
CHEMMEDCHEM (2016)
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Hong Zheng et al.
CLINICAL CANCER RESEARCH (2016)
Inside HDACs with more selective HDAC inhibitors
Joelle Roche et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases
Alokta Chakrabarti et al.
FUTURE MEDICINAL CHEMISTRY (2016)
HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells
Tanushree Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors
Daniel A. Rodrigues et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket
Alexa A. Tabackman et al.
JOURNAL OF STRUCTURAL BIOLOGY (2016)
Development of a Potent and Selective HDAC8 Inhibitor
Oscar J. Ingham et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
HDAC inhibitors with PD-1 blockade: a promising strategy for treatment of multiple cancer types?
Amer A. Beg et al.
EPIGENOMICS (2016)
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
Elizabeth E. Hull et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors
Jelena Melesina et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)
HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation
I. Rettig et al.
CELL DEATH & DISEASE (2015)
Clinical utility gene card for: Cornelia de Lange syndrome
Feliciano J. Ramos et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation
J. S. Aher et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2015)
Design of dual MMP-2/HDAC-8 inhibitors by pharmacophore mapping, molecular docking, synthesis and biological activity
Amit K. Halder et al.
RSC ADVANCES (2015)
Histone Deacetylase Inhibition Attenuates Cardiac Hypertrophy and Fibrosis through Acetylation of Mineralocorticoid Receptor in Spontaneously Hypertensive Rats
Seol-Hee Kang et al.
MOLECULAR PHARMACOLOGY (2015)
Compromised Structure and Function of HDAC8 Mutants Identified in Cornelia de Lange Syndrome Spectrum Disorders
Christophe Decroos et al.
ACS CHEMICAL BIOLOGY (2014)
A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
Ki Cheong Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8-Selective Inhibitors
Takayoshi Suzuki et al.
CHEMMEDCHEM (2014)
Current Treatment and Management of Dystrophinopathies
Nathalie Goemans et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance
Frank J. Kaiser et al.
HUMAN MOLECULAR GENETICS (2014)
Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
Guozhi Tang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania
Laura Stertz et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2014)
Fibroblasts in fibrosis: novel roles and mediators
Ryan T. Kendall et al.
FRONTIERS IN PHARMACOLOGY (2014)
HDAC8 substrates: Histones and beyond
Noah A. Wolfson et al.
BIOPOLYMERS (2013)
Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
Nambirajan Govindarajan et al.
EMBO MOLECULAR MEDICINE (2013)
Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif
Florence F. Wagner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
David E. Olson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Inflammasomes in wound healing and fibrosis
Carol M. Artlett
JOURNAL OF PATHOLOGY (2013)
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
Silvia Consalvi et al.
MOLECULAR MEDICINE (2013)
Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors
Indrek Koppel et al.
NEUROPHARMACOLOGY (2013)
Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
W. Yan et al.
ONCOGENE (2013)
HDAC inhibitors in experimental liver and kidney fibrosis
Katrien Van Beneden et al.
FIBROGENESIS & TISSUE REPAIR (2013)
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C6 position
Sun Ea Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Plant HDAC inhibitor chrysin arrest cell growth and induce p21WAF1 by altering chromatin of STAT response element in A375 cells
Manika Pal-Bhadra et al.
BMC CANCER (2012)
Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors
Wei-Jan Huang et al.
CHEMMEDCHEM (2012)
Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
Praveer Gupta et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Chrysin: A Histone Deacetylase 8 Inhibitor with Anticancer Activity and a Suitable Candidate for the Standardization of Chinese Propolis
Li-Ping Sun et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries
Takayoshi Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Matthew A. Deardorff et al.
NATURE (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
NMR Profiling of Histone Deacetylase and Acetyl-transferase Activities in Real Time
Alexander Dose et al.
ACS CHEMICAL BIOLOGY (2011)
Histone deacetylase activators: N-acetylthioureas serve as highly potent and isozyme selective activators for human histone deacetylase-8 on a fluorescent substrate
Raushan K. Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity
Sun Ea Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Discovery of histone deacetylase 8 selective inhibitors
Weiping Tang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity
Magdalena Karolczak-Bayatti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Development of Tetrahydroisoquinoline-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities
Yingjie Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design, Synthesis, Docking, and Biological Evaluation of Novel Diazide-Containing Isoxazole- and Pyrazole-Based Histone Deacetylase Probes
Raghupathi Neelarapu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer
Soon Young Park et al.
ONCOLOGY REPORTS (2011)
Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
Maoyin Pang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
An Acetylation Switch Modulates the Transcriptional Activity of Estrogen-Related Receptor α
Brian J. Wilson et al.
MOLECULAR ENDOCRINOLOGY (2010)
Abrogation of TGF-β1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition
Weichao Guo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Combining Mass Spectrometry and Peptide Arrays to Profile the Specificities of Histone Deacetylases
Zachary A. Gurard-Levin et al.
CHEMBIOCHEM (2009)
Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors
Paola Galletti et al.
CHEMMEDCHEM (2009)
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme et al.
CLINICAL CANCER RESEARCH (2009)
Targeting of HDAC8 and investigational inhibitors in neuroblastoma
Ina Oehme et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells
Yong Wang et al.
NEUROSCIENCE LETTERS (2009)
Structural Studies of Human Histone Deacetylase 8 and Its Site-Specific Variants Complexed with Substrate and Inhibitors
Daniel P. Dowling et al.
BIOCHEMISTRY (2008)
Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin
Fang Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
S. Balasubramanian et al.
LEUKEMIA (2008)
Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex
Alessandro Vannini et al.
EMBO REPORTS (2007)
Factors affecting the substrate specificity of histone deacetylases
Daniel Riester et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: Multiple mechanisms of action
Hyeon Ju Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model
Caroline Rouaux et al.
JOURNAL OF NEUROSCIENCE (2007)
Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors
Keris KrennHrubec et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structural requirements of HDAC inhibitors: SAHA analogs functionalized a lacent to the hydroxamic acid
Anton V. Bieliauskas et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Distribution of histone deacetylases 1-11 in the rat brain
Ron S. Broide et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates
Cyril Boyault et al.
GENES & DEVELOPMENT (2007)
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
G. C. Minetti et al.
NATURE MEDICINE (2006)
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
S Camelo et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases
JR Somoza et al.
STRUCTURE (2004)
The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain
KL Durst et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
